Dolby Laboratories

DLB Industrials Specialty Business Services

Dolby Laboratories' revenue for fiscal 2025 (year ended September 2025) was $1.3 billion, up 5.92% from fiscal 2024.

Revenue
−3.34%
EPS
−37.5%
Free cash flow
+157.4%

Quarter to June 2026, against a year earlier

64.77 1.45 +2.29%
Market cap
$5.9B
P/E
26.7×
Fwd P/E
20.0×
Dividend yield
2.26%
F-score
6/9
Altman Z
9.17
Beneish M
−2.80
Dividend safety
85/100

Dolby Laboratories 8-K filed Aug 27, 2026

Period ended Aug 25, 2026 · Filed · accepted 9:00 AM ET · Document on sec.gov · Filing index

5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits

Red flags